UNSPSC 51201653: COVID19 - Pfizer Biontech

The Pfizer-BioNTech COVID-19 vaccine is used to provide protection against COVID-19, caused by infection with the SARS-CoV-2 virus, by eliciting an immune response to the S antigen. The vaccine is used to reduce morbidity and mortality from COVID-19.

UNSPSC 51201653 COVID19 - Pfizer Biontech is a Commodity code that state and local health departments use to procure vaccines and related immunization products. The code's nominal designation references Pfizer-BioNTech COVID-19 vaccine, but recent procurement activity shows broader vaccine procurement — including yellow fever immunization — reflecting the practical scope of state health-agency purchasing under this classification. State and local health departments, particularly state departments of health, are the primary issuing bodies soliciting under this code. Procurement activity emphasizes critical public health supply chains where sole-source justifications may apply, especially for vaccines with limited approved sources or restricted manufacturer networks.

The Mississippi State Department of Health posted a sole-source procurement notice (3150006922, 1301-27-R-RFIN-00001) on July 13, 2026 for yellow fever vaccine from Sanofi Pasteur, Inc., with an objection deadline of August 3, 2026 at 10:00 a.m. CST. The notice invites written objections demonstrating availability from alternative vendors; substantiated objections trigger competitive bidding, while unsupported sole-source findings go to the Public Procurement Review Board. The solicitation does not specify quantity, contract term, estimated value, or pricing. Recent activity is limited; the code shows minimal state and local procurement volume in the dataset, with this sole-source vaccine procurement as the only recent documented opportunity.